Hematology/Oncology

Top Story

Fatigue tied to low physical activity in survivors of thyroid cancer

July 24, 2017

Low physical activity level may increase fatigue in survivors of thyroid cancer, especially among those who are unemployed or disabled, according to findings published in Thyroid.

Anna M. Sawka, MD, PhD, FRCPC, an associate professor in the department of medicine, division of endocrinology at Toronto General Hospital and University Health Network, and colleagues evaluated 205 adult (mean age, 52.5 years; 152 women) thyroid cancer survivors who completed a survey to determine the severity and prevalence of moderate and severe fatigue as well as potential predictive factors, including physical activity. The Brief Fatigue Inventory was used to measure global fatigue score, and the 7-day International Physical Activity Questionnaire was used to evaluate physical activity.

Seattle Genetics, Genentech to collaborate on trial for metastatic triple-negative breast cancer

July 24, 2017
Seattle Genetics and Genentech entered a clinical collaboration to evaluate SGN-LIV1A in combination with atezolizumab for the treatment of metastatic triple-negative…

NCI, Children’s Oncology Group collaborate on trial to evaluate targeted drugs for pediatric cancers

July 24, 2017
NCI and the Children’s Oncology Group today announced enrollment opened for a phase 2 study designed to evaluate targeted therapies in children and adolescents…
In the Journals

Occult HBV does not affect HCC resection outcomes

July 24, 2017
The presence of hepatitis B core antibody, or HBcAb, did not affect the outcomes of hepatic resection in patients with either hepatitis C-related or non-B, non-C…
FDA News

FDA expands indication of Yervoy to include pediatric patients with melanoma

July 24, 2017
The FDA expanded the indication of ipilimumab to include the treatment of unresectable or metastatic melanoma in patients aged 12 years or older, according to the…
More News Headlines »
CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
Video
Meeting News

VIDEO: LATITUDE, STAMPEDE trials provide ‘practice-changing’ findings in prostate cancer

July 15, 2017
More »
Resource Centers
Biosimilars in the US

Biosimilars in the US

CME

Combination Strategies in Melanoma Management: What’s New and What’s Next

This activity is supported by an educational grant from Genentech, Inc.

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement